ClinicalTrials.gg
RecruitingNCT07847424HEAT-RPAUpdated Sep 29, 2026

Heat Therapy During Reduced Physical Activity

An interventional study of Sauna and Reduced Physical Activity in Physical Inactivity, Vascular Dysfunction and Skeletal Muscle Atrophy, sponsored by Brigham Young University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Brigham Young University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jan 2026, registered Jul 2026).
  • Started Jan 2026; still recruiting 10 months later.
Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 452 studies in Sedentary Behavior with a site in United States — 61 open to participants now, 89 under way, none of them phase 3. Sedentary Behavior · United States.

Planned enrollment
196th of 421
60 · median 60
Started
2026
with 20 others
No phase
386 of 452
54 open now
Primary completion
2027-01
later than 39 of 88 live
Registered
447th of 452
by date

Among the 452 studies in Sedentary Behavior with a site in United States, this one is the 196th largest by planned enrollment of the 421 interventional ones that give a count, is one of 21 that started in 2026, is one of 386 with no phase, reaches primary completion later than 39 of the 88 other live ones, and was the 447th registered.

Sedentary Behavior

1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.

Browse Sedentary Behavior studies →

Open to participants now

61 of the 452 studies in Sedentary Behavior with a site in United States are open now. Recruiting first, the newest first:

55 more — sign in →

All 61 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 452 studies in Sedentary Behavior with a site in United States, or all of them as a file.
02

Study summary

The purpose of this randomized controlled trial is to determine whether daily Finnish dry sauna therapy attenuates the adverse cardiovascular, muscular, and metabolic effects of seven days of experimentally reduced physical activity in healthy adults.

Participants will be randomized to one of three groups: (1) maintained habitual physical activity with daily sauna therapy, (2) reduced physical activity with daily room-temperature sauna visits (control), or (3) reduced physical activity with daily sauna therapy. Reduced physical activity will be achieved by decreasing daily step count to approximately 1,000 steps per day with the assistance of a power wheelchair.

Outcome measures include vascular endothelial function, exercise tolerance, muscle protein synthesis, body composition, blood pressure, glucose regulation, and physiological responses to heat exposure. The study will determine whether passive heat therapy can serve as a practical intervention to preserve cardiometabolic health during short periods of reduced mobility.

Read the detailed description

Reduced physical activity resulting from illness, injury, hospitalization, or other temporary limitations rapidly impairs cardiovascular, skeletal muscle, and metabolic health. Even short-term reductions in daily physical activity are associated with decreased endothelial function, reduced aerobic capacity, loss of muscle mass, and impaired insulin sensitivity.

Previous work from our laboratory has demonstrated that localized heat therapy producing exercise-like increases in muscle temperature attenuates several detrimental adaptations associated with limb immobilization. The present study investigates whether whole-body heat therapy delivered through Finnish dry sauna bathing can similarly reduce the adverse effects of whole-body reductions in physical activity.

Healthy adults will be randomly assigned to one of three intervention groups:

  • Habitual physical activity with daily Finnish dry sauna therapy
  • Reduced physical activity (\~1,000 steps/day) with daily room-temperature sauna visits
  • Reduced physical activity (\~1,000 steps/day) with daily Finnish dry sauna therapy

The intervention will last seven days. Cardiovascular function, exercise tolerance, muscle protein synthesis, body composition, glucose regulation, blood pressure, and additional physiological variables will be assessed before and after the intervention. The findings will determine whether passive heat therapy is an effective strategy for preserving cardiometabolic health during temporary reductions in physical activity.

03

Conditions studied

  • Physical Inactivity
  • Vascular Dysfunction
  • Skeletal Muscle Atrophy

Keywords

  • Heat Therapy
  • Physical Inactivity
  • Sauna
  • Disuse
  • Protein Synthesis
  • Vascular Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older
  • Healthy men and premenopausal women
  • Able and willing to provide written
  • Able to perform knee-extension cycling exercise
  • Stable habitual physical activity for at least 3 months before enrollment
  • Pass the American College of Sports Medicine (ACSM) Preparticipation Health Screening
  • Not currently taking medications known to affect cardiovascular function (e.g., antihypertensive medications or beta-blockers)
  • No regular sauna or hot-tub use (fewer than six exposures during the previous 2 months)
  • Willing and able to comply with all study procedures, including temporary reduction of physical activity, daily sauna visits, physiological testing, and follow-up assessments

Exclusion criteria

Exclusion Criteria:

  • Younger than 18 years of age
  • Failure to pass the ACSM Preparticipation Health Screening
  • Unable or unwilling to perform exercise testing
  • Current cigarette or marijuana use
  • Pregnant or planning to become pregnant during the study
  • History or current diagnosis of cardiovascular disease, metabolic disease, or cognitive impairment
  • Use of medications known to influence cardiovascular function or exercise tolerance (e.g., antihypertensive medications or beta-blockers)
  • Regular sauna or hot-tub use (six or more exposures during the previous 2 months)
  • History of heat-related illness
  • Any condition that, in the opinion of the investigators, would interfere with safe participation or interpretation of study results
  • Inability to understand the study procedures or provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Habitual Physical Activity + Sauna

    Participants will maintain their habitual level of physical activity for seven consecutive days while undergoing one supervised Finnish dry sauna session each day. Sauna treatments will consist of standard Finnish dry sauna exposure according to the study protocol. Participants will undergo comprehensive cardiovascular, muscular, metabolic, and physiological assessments before and after the intervention.

    Device: Sauna

  • Sham comparator
    Reduced Physical Activity + Room-Temperature Sauna (Control)

    Participants will reduce daily physical activity to approximately 1,000 steps per day for seven consecutive days with assistance from a power wheelchair. Participants will attend daily room-temperature sauna sessions that replicate the timing and environment of the sauna intervention without therapeutic heat exposure. Comprehensive outcome assessments will be completed before and after the intervention.

    Behavioral: Reduced Physical Activity

  • Experimental
    Reduced Physical Activity + Dry Sauna

    Participants will reduce daily physical activity to approximately 1,000 steps per day for seven consecutive days with assistance from a power wheelchair while also completing one supervised Finnish dry sauna session each day. Outcome measures will be assessed before and after the intervention to determine whether heat therapy attenuates the adverse physiological effects of reduced physical activity.

    Device: Sauna · Behavioral: Reduced Physical Activity

Interventions

  • DeviceSauna

    Participants will complete one supervised dry sauna session each day for seven consecutive days. Sauna exposure will be delivered according to the study protocol using a standard Finnish dry sauna.

  • BehavioralReduced Physical Activity

    Participants will reduce daily step count to approximately 1,000 steps per day for seven consecutive days. A power wheelchair will be used to assist participants in minimizing ambulation while maintaining normal daily activities.

06

What researchers measure

Primary outcomes

  1. Femoral artery endothelial function

    Common femoral artery blood flow will be measured using Doppler ultrasound at rest and during passive movement of the lower leg through approximately 90 degrees of motion. The hyperemic response may be expressed as peak blood flow, change from resting blood flow, and/or blood-flow area under the curve. The change from baseline to post-intervention will be compared among groups.

    Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)

  2. Change in Maximum Knee-Extension Cycling Power

    Maximum exercise power will be determined during a graded knee-extension cycling test in which resistance is progressively increased until the participant can no longer maintain the required cadence. Maximum power will be reported in watts.

    Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)

  3. Change in Whole-Body Lean Mass

    Whole-body lean mass will be measured using dual-energy X-ray absorptiometry. Lean mass will be reported in kilograms, and the change from baseline to post-intervention will be compared among groups.

    Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)

  4. Integrated Skeletal Muscle Protein Synthesis Rate

    The integrated fractional synthesis rate of skeletal muscle protein will be determined using deuterium oxide labeling and vastus lateralis muscle biopsies. Deuterium incorporation into newly synthesized muscle protein will be quantified by mass spectrometry and expressed as the fractional synthesis rate over the study period, such as percentage per day. Rates will be compared among the three intervention groups.

    Time frame: Baseline (Day -4) and Day 8

Secondary outcomes

  1. Change in Leg Lean Mass

    Regional leg lean mass will be measured using dual-energy X-ray absorptiometry and reported in kilograms. The change from baseline to post-intervention will be compared among groups.

    Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)

  2. Change in Mean Interstitial Glucose Concentration

    Interstitial glucose concentrations will be monitored using a continuous glucose monitor. Mean glucose concentration will be calculated for the habitual-activity or baseline monitoring period and for the 7-day intervention period and reported in milligrams per deciliter.

    Time frame: Days -4, -3, -2, -1, 0, 1, 2, 3, 4, 5, 6, 7, 8

  3. Mean Daily Step Count During the Intervention

    Daily physical activity will be measured using an accelerometer worn on the wrist, ankle, or waist. Mean steps per day during the 7-day intervention will be used to assess adherence to the habitual-activity or reduced-activity assignment.

    Time frame: Days -4, -3, -2, -1, 0, 1, 2, 3, 4, 5, 6, 7, 8

  4. Change in Core Temperature During Sauna Exposure

    Core temperature will be measured using an esophageal temperature probe during the first and final sauna treatments. The change from pre-sauna temperature to peak temperature during sauna will be reported in degrees Celsius.

    Time frame: Day 1 and Day 8

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because participant consent did not include public data sharing, and protection of participant confidentiality is a priority.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.

Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 12 months is below that.

Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Sep 29, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Jan 2027
CompletionEst.
May 2027
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07847424
Lead sponsor
Brigham Young University
Responsible party
Rob Hyldahl (Associate Professor, Brigham Young University) — Principal investigator
First posted
Sep 29, 2026
Start date
Jan 1, 2026
Primary completion
Jan 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Robert D Hyldahl, PhD
Contact
robhyldahl@byu.edu
8014221237
Jayson R Gifford, PhD
Contact
jaysongifford@byu.edu
8014223090
Robert D Hyldahl, PhD
principal investigator · Brigham Young University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion